Search in our transfection database

Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.

Over 6000 publications, 1000 cell lines and primary cells available.

Order by :  
Found 112 results :
Cell Linein vitro
in vivo
Delivered MoleculeReagentResults & Citations
HEK-293 6Ein vitroDNAFectoPRO
Fierle JK. et al. (2019)

Sci Rep 9, 12815
Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery
More details
CHO-Sin vitroDNAFectoPRO
Tanaka S. et al. (2022)

Cell Rep ,
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display
More details
Expi293Fin vitroDNAFectoPRO
Ou T. et al. (2022)

Mol Ther 30, 184-197
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire
More details
HEK-293-Fin vitroDNAFectoPRO
Batonick, M. et al. (2016)

J Immunol Methods 431, 22-30
pMINERVA: A donor-acceptor system for the in vivo recombineering of scFv into IgG molecules
More details
HEK-293-Fin vitroDNAFectoPRO
Carravilla, P. et al. (2019)

Nat Commun 10, 78
Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions
More details
HEK-293-F, HEK-293Tin vitroDNAFectoPRO
Choi, RJ. et al. (2020)

Viruses 12, 684
BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody
More details
HEK-293in vitroDNAFectoPRO
Kaku Y. et al. (2020)

Jpn J Infect Dis 73, 235-241
Prediction of contact residues in anti-HIV neutralizing antibody by deep learning
More details
-in vitroDNAFectoPRO
Tao Y. et al. (2019)

Elife 8, 46134
Tailored Tetravalent Antibodies Potently and Specifically Activate Wnt/Frizzled Pathways in Cells, Organoids and Mice
More details
HEK-293in vitroDNAFectoPRO
Suryamohan K. et al. (2021)

Commun Biol 4,
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
More details
Expi293 GnTI−, Expi293Fin vitroDNAFectoPRO
Yin Y. et al. (2021)

Proc Natl Acad Sci U S A. 118,
In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25
More details

Give your feedback!